NDC 11673-704 - Multi Symptom Cold and Multi Symptom Nighttime Cold Childrens
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 11673-704
- Package NDCs from labels
- 11673-704-04
- Manufacturer
- TARGET Corporation
- Effective date
- 2024-06-04
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Multi Symptom Cold Daytime Childrens - TARGET Corporation | TARGET Corporation | 2024-06-04 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 11673-704-04 | Multi Symptom Cold and Multi Symptom Nighttime ColdChildrens | 118 mL in 1 BOTTLE, PLASTIC | LIQUID | 118 mL | 5 mg in 5mL | 5 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 11673-704 | MULTI SYMPTOM COLD AND MULTI SYMPTOM NIGHTTIME COLD CHILDRENS (DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCI, ACETAMINOPHEN, DIPHENHYDRAMINE HCI, PHENYLEPHRINE HCI) KIT [TARGET CORPORATION] | 5 | Unmatched | 20240606_e3da3003-88e3-4431-8b65-e61e17728901.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| CVS Health Four Actions Nasal Decongestant | PHENYLEPHRINE HYDROCHLORIDE | CVS Pharmacy,Inc. | c91b5525-6afb-4fea-afcb-9c4578075975 | 2016-09-22 | Warnings | 04JA59TNSJ |
| Sterile Water | WATER | Baxter Healthcare Company | 210dc9ab-d6ca-4552-ac19-1be17792d290 | 2016-05-31 | Warnings, Adverse reactions | 059QF0KO0R |
| CPDA-1 | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE | Fenwal, Inc. | 051f7347-5a76-4664-8fe2-e61b3dfcb0e4 | 2014-08-27 | XF417D3PSL |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.